Danielle Antalffy
Stock Analyst at UBS
(3.56)
# 828
Out of 5,056 analysts
188
Total ratings
47.71%
Success rate
5.96%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMCI Treace Medical Concepts | Maintains: Neutral | $6.5 → $5.85 | $3.33 | +75.94% | 8 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $96 → $88 | $90.03 | -2.25% | 6 | Nov 6, 2025 | |
| INMD InMode | Maintains: Neutral | $16 → $16 | $14.61 | +9.51% | 5 | Nov 6, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 → $95 | $59.61 | +59.37% | 10 | Nov 3, 2025 | |
| BAX Baxter International | Maintains: Neutral | $24 → $21 | $18.70 | +12.30% | 7 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $585 → $600 | $572.45 | +4.81% | 3 | Oct 23, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $135 → $140 | $104.13 | +34.45% | 14 | Oct 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $190 → $214 | $194.39 | +10.09% | 6 | Oct 14, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Neutral | $230 → $89 | $90.91 | -2.10% | 7 | Sep 22, 2025 | |
| MDT Medtronic | Maintains: Neutral | $94 → $95 | $95.81 | -0.85% | 11 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $8 | $10.01 | -20.08% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $57 | $31.24 | +82.46% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $18.06 | -5.87% | 15 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $134 | $92.61 | +44.69% | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $33.06 | +75.44% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $7.72 | -35.23% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $128.82 | +14.89% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $367.34 | +0.72% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $85.58 | -12.36% | 12 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $2.26 | -0.44% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $280 | $336.84 | -16.87% | 12 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $5.54 | +14,791.70% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $24.09 | -41.88% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $54.50 | +83.49% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $13.50 | -11.11% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $30.77 | -2.50% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $40.44 | +11.28% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $192.12 | +43.14% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $6.48 | +208.64% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $7.09 | +492.38% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $60 | $6.59 | +810.47% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.64 | +2,247.79% | 1 | Sep 1, 2020 |
Treace Medical Concepts
Nov 7, 2025
Maintains: Neutral
Price Target: $6.5 → $5.85
Current: $3.33
Upside: +75.94%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Sell
Price Target: $96 → $88
Current: $90.03
Upside: -2.25%
InMode
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $16
Current: $14.61
Upside: +9.51%
DexCom
Nov 3, 2025
Maintains: Buy
Price Target: $106 → $95
Current: $59.61
Upside: +59.37%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $24 → $21
Current: $18.70
Upside: +12.30%
Intuitive Surgical
Oct 23, 2025
Maintains: Neutral
Price Target: $585 → $600
Current: $572.45
Upside: +4.81%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $135 → $140
Current: $104.13
Upside: +34.45%
Johnson & Johnson
Oct 14, 2025
Maintains: Buy
Price Target: $190 → $214
Current: $194.39
Upside: +10.09%
Inspire Medical Systems
Sep 22, 2025
Downgrades: Neutral
Price Target: $230 → $89
Current: $90.91
Upside: -2.10%
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94 → $95
Current: $95.81
Upside: -0.85%
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $10.01
Upside: -20.08%
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $31.24
Upside: +82.46%
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $18.06
Upside: -5.87%
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $92.61
Upside: +44.69%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $33.06
Upside: +75.44%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $7.72
Upside: -35.23%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $128.82
Upside: +14.89%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $367.34
Upside: +0.72%
Sep 10, 2024
Maintains: Neutral
Price Target: $90 → $75
Current: $85.58
Upside: -12.36%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $2.26
Upside: -0.44%
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $336.84
Upside: -16.87%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $5.54
Upside: +14,791.70%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $24.09
Upside: -41.88%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $54.50
Upside: +83.49%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $13.50
Upside: -11.11%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $30.77
Upside: -2.50%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $40.44
Upside: +11.28%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $192.12
Upside: +43.14%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $6.48
Upside: +208.64%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $7.09
Upside: +492.38%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $60
Current: $6.59
Upside: +810.47%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.64
Upside: +2,247.79%